Literature DB >> 3353436

"Crack smoke" is a respirable aerosol of cocaine base.

C A Snyder1, R W Wood, J F Graefe, A Bowers, K Magar.   

Abstract

The smoking of cocaine base [corrected] ("crack") has emerged as a significant substance abuse problem. A detailed characterization of cocaine smoke is a prerequisite for studies of its pharmacokinetics, abuse potential and toxicity. Model pipes were used to generate cocaine smoke analogous to that inhaled by human "crack" abusers. Using procedures to minimize pyrolysis, cocaine base smoke was determined to be 93.5% cocaine particles with the remainder being cocaine vapor. The average particle size generated from all model pipes was 2.3 mu which is small enough to ensure deposition into the alveolar region of the human lung. Although this particle size is eminently respirable [corrected] by primates, a much smaller fraction will reach the alveolar region of rodents. Special generating procedures would therefore be required to expose rodents to meaningful doses of airborne cocaine that mimic the rapid absorption achieved by "crack" smokers.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3353436     DOI: 10.1016/0091-3057(88)90280-8

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  4 in total

Review 1.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

2.  Rats self-administer sufentanil in aerosol form.

Authors:  A B Jaffe; L G Sharpe; J H Jaffe
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  The persistence of illicit drug smoke residues and their recovery from common household surfaces.

Authors:  Julie L Bitter
Journal:  Drug Test Anal       Date:  2016-06-22       Impact factor: 3.345

4.  Discriminative stimulus effects of inhaled cocaine in squirrel monkeys.

Authors:  J L Katz; L G Sharpe; J H Jaffe; E I Shores; J M Witkin
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.